Compound Detail
CHEMBL5283845
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5283845 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PEYZIVLALWLEEG-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
407.3
MW (Da)
4.07
ALogP
2
HBA
3
HBD
73.0
PSA (Ų)
0.46
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.08
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sortase A CHEMBL5362 | IC50 | 4.08 | 4.08 | 83200.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Sortase A | IC50 | = | 83200.0 | nM | 4.08 | Inhibition of Staphylococcus aureus SrtA using EDANS-Dabcyl as substrate by FRET... | 34516107 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34516107 | 10.1021/acs.jmedchem.1c00386 | Sortase A | 1 |
Data from ChEMBL 36 via Core Engine